72359-001Level 3
RETHYMIC (allogenic thymocyte-depleted thymus tissue-agdc)
**Product type:** Human Prescription Drug
**Active ingredient:** ALLOGENEIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC
**Strength:** 22000 mm/1
**Dosage form:** Implant
**Route:** Intramuscular
**Labeler:** Sumitomo Pharma America, Inc.
**Marketing category:** BLA (BLA125685)
GET
/api/v1/systems/ndc_fda/nodes/72359-001Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.